SCHEMBL26645258

SCHEMBL26645258

Fc1cc(-c2cc3n(n2)CCNC3)ccc1Cl

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PDCD1 Q15116 1/20 0.47
CD274 Q9NZQ7 1/20 0.47
KMO O15229 2/20 0.36
EGLN2 Q96KS0 1/20 0.35
HTR2A P28223 4/20 0.35
HTR2C P28335 4/20 0.35
PDE4A P27815 3/20 0.34
PDE4B Q07343 3/20 0.34
PDE4C Q08493 3/20 0.34
JAK2 O60674 1/20 0.33
JAK1 P23458 1/20 0.33
TYK2 P29597 1/20 0.33
JAK3 P52333 1/20 0.33
PDE4D Q08499 1/20 0.33
ABL1 P00519 1/20 0.33
NPC1 O15118 1/20 0.33
LMNA P02545 1/20 0.33
RAB9A P51151 1/20 0.33
SMN1; SMN2 Q16637 1/20 0.33
HTR2B P41595 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16700558 0.82 PDCD1 (0.52) PDCD1CD274HTR2AHTR2CHTR2B
SCHEMBL26645109 0.81 PDCD1 (0.47) PDCD1CD274HTR2AHTR2CNPC1
SCHEMBL30623111 0.81 PDCD1 (0.47) PDCD1CD274HTR2AHTR2CNPC1
SCHEMBL26645467 0.79 PDCD1 (0.47) PDCD1CD274KMOHTR2AHTR2C
SCHEMBL30622782 0.79 PDCD1 (0.47) PDCD1CD274KMOHTR2AHTR2C
SCHEMBL16699354 0.78 PDCD1 (0.58) PDCD1CD274HTR2AHTR2CLMNA
SCHEMBL24276975 0.77 PDCD1 (0.53) PDCD1CD274JAK2JAK1TYK2
SCHEMBL26645268 0.76 PDCD1 (0.50) PDCD1CD274KMOEGLN2HTR2A
SCHEMBL26645648 0.76 PDCD1 (0.49) PDCD1CD274HTR2AHTR2CHTR2B
SCHEMBL26645568 0.75 CDC7 (0.61) KMOEGLN2PDE4APDE4BPDE4C

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4519265-A1 IRREVERSIBLE MUTEGFR INHIBITORS Bayer Aktiengesellschaft (DE) 2025-03-12 EP disclosed
WO-2023213882-A1 IRREVERSIBLE MUTEGFR INHIBITORS BAYER AKTIENGESELLSCHAFT (DE) 2023-11-09 WO disclosed